US Stock MarketDetailed Quotes

AGNPF ALGERNON PHARMACEUTICALS INC

Watchlist
  • 0.087200
  • -0.001800-2.02%
15min DelayClose Apr 25 16:00 ET
1.89MMarket Cap-425P/E (TTM)

ALGERNON PHARMACEUTICALS INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
(Q3)May 31, 2022
(Q2)Feb 28, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-72.24%521.97K
-12.92%5.24M
-54.80%985.85K
40.80%1.13M
-32.06%1.25M
56.56%1.88M
-25.23%6.02M
299.45%2.18M
-52.21%801.17K
-23.09%1.84M
Selling and administrative expenses
-77.05%335.53K
12.65%3.94M
-42.59%762.75K
-8.49%602.08K
11.96%1.11M
169.81%1.46M
13.44%3.49M
80.45%1.33M
8.46%657.91K
15.22%991.61K
-Selling and marketing expense
-81.87%104.86K
72.75%1.26M
-35.93%217.7K
26.41%155.55K
148.79%309.16K
305.26%578.3K
-8.12%729.8K
44.64%339.78K
-31.88%123.05K
-44.36%124.27K
-General and administrative expense
-73.89%230.66K
-3.22%2.68M
-44.87%545.05K
-16.51%446.53K
-7.65%800.99K
121.38%883.41K
20.93%2.76M
97.23%988.71K
25.57%534.86K
36.10%867.34K
Research and development costs
-52.95%167.58K
-52.25%1.1M
-76.88%188.36K
427.98%460.58K
-88.22%90.06K
-43.17%356.17K
-52.19%2.29M
493.11%814.69K
-91.59%87.23K
-47.66%764.8K
Other operating expenses
-69.78%18.87K
-9.33%210.13K
-8.53%34.74K
16.68%65.37K
-40.66%47.58K
91.78%62.44K
33.72%231.76K
122.50%37.98K
75.07%56.03K
21.28%80.18K
Operating profit
72.24%-521.97K
12.92%-5.24M
54.80%-985.85K
-40.80%-1.13M
32.06%-1.25M
-56.56%-1.88M
25.23%-6.02M
-299.45%-2.18M
52.21%-801.17K
23.09%-1.84M
Net non-operating interest income expense
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
-36.77%294
-82.58%2.08K
-28.83%464
-75.79%550
-77.78%599
Non-operating interest income
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
-36.77%294
-82.58%2.08K
-28.83%464
-75.79%550
-77.78%599
Other net income (expense)
-4,125.19%-1.54M
-111.96%-36.48K
Special income (charges)
----
-4,125.19%-1.54M
----
----
----
----
---36.48K
----
----
----
-Less:Impairment of capital assets
----
4,125.19%1.54M
----
----
----
----
--36.48K
----
----
----
Income before tax
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
23.03%-1.84M
Income tax
Net income
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
23.03%-1.84M
Net income continuous Operations
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
23.03%-1.84M
Minority interest income
Net income attributable to the parent company
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
23.03%-1.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
23.03%-1.84M
Basic earnings per share
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
-32.62%-0.2
16.43%-0.87
-4,514.89%-0.29
43.28%-0.12
21.88%-0.27
Diluted earnings per share
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
-32.62%-0.2
16.43%-0.87
-4,514.89%-0.29
43.28%-0.12
21.88%-0.27
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022(Q3)May 31, 2022(Q2)Feb 28, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -72.24%521.97K-12.92%5.24M-54.80%985.85K40.80%1.13M-32.06%1.25M56.56%1.88M-25.23%6.02M299.45%2.18M-52.21%801.17K-23.09%1.84M
Selling and administrative expenses -77.05%335.53K12.65%3.94M-42.59%762.75K-8.49%602.08K11.96%1.11M169.81%1.46M13.44%3.49M80.45%1.33M8.46%657.91K15.22%991.61K
-Selling and marketing expense -81.87%104.86K72.75%1.26M-35.93%217.7K26.41%155.55K148.79%309.16K305.26%578.3K-8.12%729.8K44.64%339.78K-31.88%123.05K-44.36%124.27K
-General and administrative expense -73.89%230.66K-3.22%2.68M-44.87%545.05K-16.51%446.53K-7.65%800.99K121.38%883.41K20.93%2.76M97.23%988.71K25.57%534.86K36.10%867.34K
Research and development costs -52.95%167.58K-52.25%1.1M-76.88%188.36K427.98%460.58K-88.22%90.06K-43.17%356.17K-52.19%2.29M493.11%814.69K-91.59%87.23K-47.66%764.8K
Other operating expenses -69.78%18.87K-9.33%210.13K-8.53%34.74K16.68%65.37K-40.66%47.58K91.78%62.44K33.72%231.76K122.50%37.98K75.07%56.03K21.28%80.18K
Operating profit 72.24%-521.97K12.92%-5.24M54.80%-985.85K-40.80%-1.13M32.06%-1.25M-56.56%-1.88M25.23%-6.02M-299.45%-2.18M52.21%-801.17K23.09%-1.84M
Net non-operating interest income expense 42.86%4200.91%2.1K64.01%76133.45%734-48.58%308-36.77%294-82.58%2.08K-28.83%464-75.79%550-77.78%599
Non-operating interest income 42.86%4200.91%2.1K64.01%76133.45%734-48.58%308-36.77%294-82.58%2.08K-28.83%464-75.79%550-77.78%599
Other net income (expense) -4,125.19%-1.54M-111.96%-36.48K
Special income (charges) -----4,125.19%-1.54M-------------------36.48K------------
-Less:Impairment of capital assets ----4,125.19%1.54M------------------36.48K------------
Income before tax 72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K23.03%-1.84M
Income tax
Net income 72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K23.03%-1.84M
Net income continuous Operations 72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K23.03%-1.84M
Minority interest income
Net income attributable to the parent company 72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K23.03%-1.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K23.03%-1.84M
Basic earnings per share 85.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13-32.62%-0.216.43%-0.87-4,514.89%-0.2943.28%-0.1221.88%-0.27
Diluted earnings per share 85.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13-32.62%-0.216.43%-0.87-4,514.89%-0.2943.28%-0.1221.88%-0.27
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg